Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza
JAMAPublished 24 January 1996
Frederick G. Hayden
Citations280
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Direct respiratory administration of the selective neuraminidase inhibitor GG167 appears safe and effective for both prevention and early treatment of experimental influenza.
Abstract
Direct respiratory administration of the selective neuraminidase inhibitor GG167 appears safe and effective for both prevention and early treatment of experimental influenza. Influenza virus neuraminidase is important for viral replication in humans.
Keywords
Immunology and MicrobiologyMedicine
NatureRational design of potent sialidase-based inhibitors of influenza virus replication
1,860 Citations1993Mark von Itzstein, Wen‐Yang Wu +16 more
Two potent inhibitors based on the crystal structure of influenza virus sialidase have been designed and provide an example of the power of rational, computer-assisted drug design, indicating significant progress in the development of a new therapeutic or prophylactic treatment for influenza infection.
NatureStructure of the catalytic and antigenic sites in influenza virus neuraminidase
807 Citations1983P.M. Colman, J.N. Varghese +1 more
The catalytic sites of influenza virus neuraminidase are located on the upper corners of the box-shaped tetramer that forms the head of the molecule, and determinants form a nearly-continuous surface across the top of the monomer encircling the catalytic site.
VirologyCharacterization of temperature sensitive influenza virus mutants defective in neuraminidase
796 Citations1974Peter Palese, Kiyotake Tobita +2 more
The results suggest that the lack of hemagglutinating activity of mutant virus grown at 39.5° is a consequence of the formation of aggregates of virus particles carrying neuraminic acid on their surface, and that the ts defect is in the neuraminidase but not the hemagGLutinin molecule.
Proteins Structure Function and BioinformaticsThe structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor
406 Citations1992Joseph Varghese, Jennifer L. McKimm‐Breschkin +3 more
Crystallographic studies of neuraminidase–sialic acid complexes indicate that sialic Acid is distorted on binding the enzyme, and three arginine residues on the enzyme interact with the carboxylate group of the sugar.
Journal of VirologyInfluenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding
372 Citations1995C Liu, Maryna C. Eichelberger +2 more
It is suggested that neuraminidase is not required for influenza virus entry, replication, or assembly in cell culture or in mice.
New England Journal of MedicineAssociation of Serum Anti-Neuraminidase Antibody with Resistance to Influenza in Man
365 Citations1972Brian R. Murphy, J. A. Kasel +1 more
The role of serum anti-neuraminidase antibody in resistance to influenzal illness was investigated by administration of wild-type influenza A/Hong Kong/1968 (H3N2) virus to volunteers who had shown resistance to Influenza A.
Journal of General VirologyInhibition of Influenza Virus Replication in Tissue Culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): Mechanism of Action
359 Citations1976Peter Palese, Richard W. Compans
The neuraminidase inhibitor 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA) inhibits the mutlicycle replication of influenza viruses in tissue culture by preventing the enzymatic removal of neuraminic Acid from the virus envelope.
Antimicrobial Agents and Chemotherapy4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro
312 Citations1993Jacqueline M. Woods, Richard C. Bethell +8 more
4-Guanidino-Neu5Ac2en represents a new potent and selective inhibitor of influenza A and B virus sialidase activity and replication in vitro in comparison with amantadine, rimantadines, and ribavirin.
VirologyInhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid
287 Citations1974Peter Meindl, G. Bodo +3 more
2-Deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid inhibits hemagglutination by NDV and SV5 but does not inhibit agglutination of red cells by Sendai virus or influenza A and B viruses.
Journal of VirologyProtective Effects of Specific Immunity to Viral Neuraminidase on Influenza Virus Infection of Mice
286 Citations1968Jerome L. Schulman, M. Khakpour +1 more
Observations suggest that antineuraminidase immunity may play a significant role in the protection against influenza virus challenge observed in mice after infection or artificial immunization.
The Journal of Infectious DiseasesInduction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine
260 Citations1974R. B. Couch, J. A. Kasel +3 more
This work presents a novel and scalable approach that allows for real-time, 3D analysis of the response of the immune system to Epstein-Barr virus.
Journal of Pharmacy and PharmacologyIntranasal drug delivery by spray and drops
250 Citations1985J G Hardy, S W Lee +1 more
The patterns of deposition and the rates of clearance in normal subjects were monitored by gamma scintigraphy, and factors have implications when designing dosage regimens for drugs administered by the intranasal route.
Journal of Molecular BiologyThree-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2·2 Å resolution
228 Citations1991J.N. Varghese, Peter M. Colman
An atomic model of the tetrameric surface glycoprotein neuraminidase of influenza virus A/Tokyo/3/67 has been built and refined based on X-ray diffraction data at 2.2 A resolution and details of the intramolecular interactions between the six beta-sheets are presented.
The LancetEFFECT OF NEURAMINIDASE ANTIBODY ON HONG KONG INFLUENZA
218 Citations1973Arnold S. Monto, Alan P. Kendal
It is concluded that antibody against the neuraminidase of the influenza virus prevented or modified infection in a situation in which haemagglutinin antibody had no effect.
New England Journal of MedicineProphylaxis and Treatment of Influenza
210 Citations1990John A. Oates, Alastair J.J. Wood +1 more
It has been over 20 years since there has been a severe influenza pandemic, Nevertheless, influenza remains an important epidemic viral infection with the potential to return to its former magnitude.
VirologyFunctional significance of sialidase during influenza virus multiplication
193 Citations1966Jane T. Seto, R. Rott
The results strongly suggest that one of the most important functions of sialidase may be for the release of virion from infected cells.
Journal of VirologyGlycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus
162 Citations1993S Li, Jerome L. Schulman +2 more
Results suggest that the absence of a glycosylation site at position 130 of the NA plays a key role in the neurovirulence of WSN virus in mice.
Glycoconjugate JournalInhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position
153 Citations1993Cindy T. Holzer, Mark von Itzstein +4 more
It is concluded that only the influenza A and B sialidase active sites possess acid groups correctly positioned to participate in charge-charge interactions in the region of C-4 of bound substrate, and that the C- 4 binding pockets of the bacterial and mammalian sIALidases examined are considerably smaller than is observed for either the influenza virus or parainfluenza virus sialids.
Antimicrobial Agents and ChemotherapyInhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase)
143 Citations1994David Ryan, John R. Ticehurst +2 more
Its potent efficacy by the intranasal route but lack of efficacy by other routes, relative to those of amantadine and ribavirin, was explicable in terms of its in vitro activity, bioavailability, and pharmacokinetic properties and with the extracellular activity of viral sialidase.
VirologyProtection against lethal influenza with neuraminidase
116 Citations1988Robert G. Webster, Philip A. Reay +1 more
Chickens vaccinated with isolated N2 in adjuvant or with inactivated H5N2 influenza virus were protected from clinical signs and death after challenge with A/Ck/Penn/1370/83 influenza virus, but these animals were completely susceptible and died of infection with a heterologous subtype of influenza virus.
VirologySelection and Characterization of a Neuraminidase-Minus Mutant of Influenza Virus and Its Rescue by Cloned Neuraminidase Genes
115 Citations1993Chongguang Liu, Gillian M. Air
A neuraminidase (NA)-deficient mutant, designated NWS-Mvi, of the reassortant influenza virus A/NWS/33HA-A/tern/Australia/G70c/75NA (H1N9), was selected by passaging virus in MDCK cells in a medium containing neuramidase from the bacterium Micromonospora viridifaciens and polyclonal antiserum against the influenza NA.
VirologyInhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA)
113 Citations1974Peter Palese, Jerome L. Schulman +2 more
FANA is a potent specific inhibitor of neuraminidase that inhibits the elution of influenza viruses from erythrocytes, and causes a marked reduction in the size of plaques produced by influenza A viruses and NDV in cell culture under agar overlay.
British Journal of Clinical PharmacologyDistribution and removal of human serum albumin‐technetium 99m instilled intranasally.
90 Citations1976F. Y. Aoki, JC Crowley
A multidose study confirmed that frequent administration by drops is required to maintain a high level of activity in the nasal cavity, and it should be possible to correlate measurements of antiviral efficacy and vaccines take-rates with certain characteristics of intranasal applicators.
Antiviral ResearchEfficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A
86 Citations1989Peter D. Reuman, David I. Bernstein +4 more
The results suggest that 100 mg/day of amantadine will reduce toxicity but maintain the prophylactic efficacy seen with 200mg/day.
The Journal of Infectious DiseasesEvaluation of a Neuraminidase-Specific Influenza A Virus Vaccine in Children: Antibody Responses and Effects on Two Successive Outbreaks of Natural Infection
80 Citations1979Karl R. Beutner, Tina C. Chow +4 more
The degree of protection after vaccination with the Heq1N2Ch vaccine was less than that provided by the biphasic H3ChN2ch vaccine against the Port Chalmers strain, but it appeared to be similar in the two vaccine study groups against the Victoria strain.
Antimicrobial Agents and ChemotherapyProtective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus
56 Citations1987S D Sears, M L Clements
Results indicate that in adults experimentally challenged with influenza wild-type virus, 100 mg of amantadine is effective both in the prevention of influenza illness and in the restriction of virus replication.
Antiviral ResearchAnti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium
55 Citations1994Frederick G. Hayden, Barbara S. Rollins +1 more
4-G-NAc is a potent and selective inhibitor of clinical isolates of influenza A and B viruses in human respiratory epithelium in Madin-Darby canine kidney cells by yield reduction and ELISA and in explants of human lungs by yield Reduction.
JAMAEvaluation of Amantadine in Artificially Induced A2 and B Influenza
52 Citations1970A. A. Smorodintsev
In double-blind placebo-controlled studies of 404 volunteers, amantadine hydrochloride was found to be 51% effective in preventing the development of artificially induced A2 influenza, and 73% to 92% effectiveIn preventing the more severe form of A1 influenza.
JAMAStudies on Induced Influenza in Man
51 Citations1968A. T. Dawkins
A single double-blind study conducted with 55 volunteers showed clearly that Exp 126 (alpha-methyl-1-adamantanemethylamine hydrochloride, rimantadine hydro chloride), an analogue of amantadines hydrochlorides, reduced the occurrence and severity of artificially induced Asian influenza in humans.
Antiviral ResearchInhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid
50 Citations1994Gary Thomas, M. Forsyth +2 more
Growth in tissue culture of viruses from each subtype was inhibited by this compound at concentrations within a range previously found effective against human N1 and N2 viruses, suggesting this compound may prove a selective agent for the treatment of influenza virus infections.
Antimicrobial Agents and ChemotherapyOral LY217896 for prevention of experimental influenza A virus infection and illness in humans
42 Citations1994Frederick G. Hayden, Allan R. Tunkel +4 more
LY217896 was associated with asymptomatic rises in serum uric acid levels and was ineffective in modifying the virologic or clinical course of experimental influenza A (H1N1) virus infection.
The Journal of Infectious DiseasesTolerance and Efficacy of Intranasal Administration of Recombinant serine Interferon in Healthy Adults
28 Citations1988S J Sperber, P. A. Levine +3 more
RIFN-beta ser may have a more favorable therapeutic ratio than do previously tested alpha interferons, and colds occurred less often in the high-dose than in the low-dose (55%) or placebo (64%) recipients.